SVA

Sinovac Biotech, Ltd
SVA

Overview Fund Activity
Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

50 hedge funds and large institutions have $74.3M invested in Sinovac Biotech, Ltd in 2014 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 20 reducing their positions, and 7 closing their positions.

Holders
50
Holders Change
-2
Holders Change %
-3.85%
% of All Funds
1.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
15
Reduced
20
Closed
7
Calls
$135K
Puts
$675K
Net Calls
-$540K
Net Calls Change
-$370K

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$941K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$6.63M
3
PAMU
3
Pictet Asset Management (UK)
United Kingdom
$3.44M
4
PRCM
4
Pine River Capital Management
Minnesota
$1.03M
5
TC
5
TFS Capital
Pennsylvania
$552K

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$22.3M
2
Jane Street
2
Jane Street
New York
$0
3
Fidelity International
3
Fidelity International
Bermuda
$5.35M
4
California Public Employees Retirement System
4
California Public Employees Retirement System
California
$458K
5
WC
5
Wexford Capital
Florida
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Jane Street
51
Jane Street
New York
– -$1.6M -222,323 Closed
WC
52
Wexford Capital
Florida
– -$403K -56,000 Closed
EMG
53
Ellington Management Group
Connecticut
– -$310K -43,000 Closed
CBOA
54
Commonwealth Bank of Australia
Australia
– -$202K -28,033 Closed
AAP
55
Ardsley Advisory Partners
Connecticut
– -$180K -25,000 Closed
BRWA
56
B. Riley Wealth Advisors
Florida
– -$161K -22,295 Closed
1 2
3